Article info
PDFCommentary
Pregnant women should not be categorised as a ‘vulnerable population’ in biomedical research studies: ending a vicious cycle of ‘vulnerability’
- Correspondence to Dr Carleigh B Krubiner, Johns Hopkins Berman Institute of Bioethics, Baltimore, MD 21205, USA; ckrubiner{at}jhu.edu
Citation
Pregnant women should not be categorised as a ‘vulnerable population’ in biomedical research studies: ending a vicious cycle of ‘vulnerability’
Publication history
- Received June 21, 2017
- Revised February 13, 2017
- Accepted June 22, 2017
- First published July 17, 2017.
Online issue publication
September 28, 2017
Article Versions
- Previous version (17 July 2017).
- Previous version (8 September 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- Vulnerability of pregnant women in clinical research
- Include pregnant women in research—particularly covid-19 research
- Risk perception, beliefs about medicines and medical adherence among pregnant and breastfeeding women with migraine: findings from a cross-sectional study in Norway
- Critical COVID-19 in a 24-week pregnant woman with 32 days of invasive mechanical ventilation before delivery of fetus: a case of successful collaborative multidisciplinary care
- Management of gastrointestinal and liver diseases during pregnancy
- Meeting the goal of concurrent adolescent and adult licensure of HIV prevention and treatment strategies
- Medication use in pregnancy: a cross-sectional, multinational web-based study
- Diagnosis and management of covid-19 in pregnancy
- Making pharmaceutical research and regulation work for women
- Use of interrupted time-series analysis to characterise antibiotic prescription fills across pregnancy: a Norwegian nationwide cohort study